Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roussel Uclaf discloses endothelin antagonists

June 21, 1996

Endothelin antagonist claimed by Roche

June 21, 1996

Thymosin beta4 as cystic fibrosis treatment

June 21, 1996

Ono reveals antioxidant TxA2 synthase/5-lipoxygenase inhibitors

June 21, 1996

Chymase/NO production inhibitors synthesized by Wakamoto

June 21, 1996

Glaxo Wellcome synthesizes protein-binding agents

June 21, 1996

Thiophenolic compounds revealed by Searle

June 21, 1996

Asahi Brewery discloses antioxidants

June 21, 1996

Schering AG claims AMPA antagonists for neurodegenerative disorders

June 21, 1996

Hoechst synthesizes NOS inhibitors

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...